Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Funding for community health centers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| DES MOINES UNIVERSITY |
| 4 |
| 2011 |
| NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE | 3 | 2012 |
| EMD SERONO, INC. | 2 | 2013 |
| PLASMA PROTEIN THERAPEUTICS ASSOCIATION | 2 | 2014 |
| SANOFI PASTEUR | 2 | 2011 |
| AVALON HEALTH MANAGEMENT | 1 | 2013 |
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AETNA, INC. · Firm: DLA PIPER LLP (US)
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AETNA, INC. · Firm: DLA PIPER LLP (US)
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
Safeguarding America's Pharmaceuticals Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 959, Pharmaceutical Compounding Quality and Accountability Act (provisions related to drug supply chain security).
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AETNA, INC. · Firm: DLA PIPER LLP (US)
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013, provisions related to health IT.
H.R. 3204, The Drug Quality and Security Act.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AETNA, INC. · Firm: DLA PIPER LLP (US)
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013, provisions related to health IT.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
Pharmaceutical Quality, Security, and Accountability Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 959, Pharmaceutical Compounding Quality and Accountability Act (provisions related to drug supply chain security).
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
2014 · fourth_quarter · 4T
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
National Diabetes Prevention Program.
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, issues related to plasma protein therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Implementation of Public Law No. 111-148, provisions related to health IT.
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
Filing targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Implementation of Public Law No. 111-148.
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Funding for community health centers.
Filing targets: Executive Office of the President (EOP)
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Implementation of Public Law No. 111-148.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via DLA PIPER LLP (US)
2014 · third_quarter · Q3
H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, issues related to plasma protein therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
Filing targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Prevention Program.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions related to health IT.
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
Filing targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Funding for community health centers.
Filing targets: Executive Office of the President (EOP)
AETNA, INC. via DLA PIPER LLP (US)
2014 · second_quarter · Q2
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
Implementation of Public Law No. 111-148, provisions related to preventative services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · first_quarter · 1A
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
AETNA, INC. via DLA PIPER LLP (US)
2014 · first_quarter · Q1
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 and H.R. 4302, Protecting Access to Medicare Act of 2014, provisions related to health IT.
Implementation of Public Law No. 111-148, provisions related to preventative services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Funding for community health centers.
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · first_quarter · Q1
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · first_quarter · RR
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
AETNA, INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology.
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013, provisions related to health IT.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
H.R. 1851/S. 881, Family Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
H.R. 1851/S. 881, Family Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology; wellness initiatives.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
H.R. 3204, The Drug Quality and Security Act.
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 959, Pharmaceutical Compounding Quality and Accountability Act (provisions related to drug supply chain security).
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
AETNA, INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology; wellness initiatives.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AETNA, INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives; health information technology; Wellness initiatives.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
National Diabetes Prevention Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AVALON HEALTH MANAGEMENT via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Implementation of the American Taxpayer Relief Act of 2012 (P.L. No. 112-240), creation of Commission on Long-Term Care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Efforts to treat and prevent emerging infectious diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives; health information technology; Wellness initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives; health information technology; Million Hearts Initiative and wellness initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
H.R. 5657, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Efforts to treat and prevent emerging infectious diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives; health information technology; Million Hearts Initiative and wellness initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · first_quarter · RR
Health care reform issues.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare and Medicaid drug rebates.
Prescription Drug User Fee Act; Reauthorization.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
FY2011 and FY2012 appropriations, provisions on anti-viral therapeutic countermeasures.
Anti-viral therapeutic countermeasures.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
FY 2012 Budget Resolution: diabetes-related issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
FY2011 and FY2012 appropriations, provisions on anti-viral therapeutic countermeasures.
Anti-viral therapeutic countermeasures.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
SANOFI PASTEUR via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Pandemic influenza, vaccine-related issues; H.Res. 295, promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with the disease.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · fourth_quarter · 4T
Implementation of the Patient Protection and Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Anti-viral therapeutic countermeasures.
FY2011 and FY2012 appropriations, provisions on anti-viral therapeutic countermeasures.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SANOFI PASTEUR via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Pandemic influenza, vaccine-related issues; H.Res. 295, promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with the disease.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Anti-viral therapeutic countermeasures.
FY2010, FY2011 and FY2012 appropriations, provisions on anti-viral therapeutic countermeasures.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Implementation of the Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · first_quarter · Q1
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · first_quarter · RR
Issues related to the prevention and treatment of diabeties; Implementation of Public Law No. 111-148.
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2011 · first_quarter · Q1
FY2010, FY2011 and FY2012 appropriations, provisions on anti-viral therapeutic countermeasures.
Anti-viral therapeutic countermeasures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · first_quarter · Q1
Implementation of the Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
National Diabetes Prevention Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FY 2012 Budget Resolution: diabetes-related issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE